Background. Very elderly subjects (VES; aged 80 years or older) constitute a special population as they frequently present multiple diseases (polypathology). Results from trials on general adult populations therefore cannot be extrapolated to VES. We performed a census of randomized controlled trials (RCT) on VES published between 1990 and 2002, and carried out a descriptive and methodological analysis of these RCT/VES, comparing them with matched RCT on general adult populations (control RCT, RCT/C). Methods. We searched for RCT/VES in two international databases (EMBASE and MEDLINE) and then manually. RCT/C were matched to RCT/VES for disease area and year of publication. The methodological quality of each RCT was assessed with Chalmers ’...
Background: Clinical trials are widely used to approve the efficacy and discover adverse reactions o...
Randomised controlled trials (RCTs) usually provide the best evidence for treatments and management....
CONTEXT: Older adults are underrepresented in clinical research. To assess therapeutic efficacy in o...
To quantify the proportion of randomized controlled trials (RCTs) specifically designed for elderly,...
To quantify the proportion of randomized controlled trials (RCTs) specifically designed for elderly,...
Background: We aimed to determine the representation of elderly people in published reports of rando...
BACKGROUND: We aimed to determine the representation of elderly people in published reports of rando...
Background: Elderly patients represent the greatest consumers of healthcare per capita but have hist...
To critically assess the external validity of randomized controlled trials (RCTs) it is important to...
To critically assess the external validity of randomized controlled trials (RCTs) it is important to...
The elderly population is a large and the fastest-growing portion of the population worldwide. The e...
Older adults are underrepresented in clinical research. To assess therapeutic efficacy in older pati...
OBJECTIVES: To investigate the inclusion of older people in clinical trials of recently authorized m...
International audienceBACKGROUND: Physicians need clinical trials assessing benefits and harms of tr...
Context: Older adults are underrepresented in clinical research. To assess therapeutic efficacy in o...
Background: Clinical trials are widely used to approve the efficacy and discover adverse reactions o...
Randomised controlled trials (RCTs) usually provide the best evidence for treatments and management....
CONTEXT: Older adults are underrepresented in clinical research. To assess therapeutic efficacy in o...
To quantify the proportion of randomized controlled trials (RCTs) specifically designed for elderly,...
To quantify the proportion of randomized controlled trials (RCTs) specifically designed for elderly,...
Background: We aimed to determine the representation of elderly people in published reports of rando...
BACKGROUND: We aimed to determine the representation of elderly people in published reports of rando...
Background: Elderly patients represent the greatest consumers of healthcare per capita but have hist...
To critically assess the external validity of randomized controlled trials (RCTs) it is important to...
To critically assess the external validity of randomized controlled trials (RCTs) it is important to...
The elderly population is a large and the fastest-growing portion of the population worldwide. The e...
Older adults are underrepresented in clinical research. To assess therapeutic efficacy in older pati...
OBJECTIVES: To investigate the inclusion of older people in clinical trials of recently authorized m...
International audienceBACKGROUND: Physicians need clinical trials assessing benefits and harms of tr...
Context: Older adults are underrepresented in clinical research. To assess therapeutic efficacy in o...
Background: Clinical trials are widely used to approve the efficacy and discover adverse reactions o...
Randomised controlled trials (RCTs) usually provide the best evidence for treatments and management....
CONTEXT: Older adults are underrepresented in clinical research. To assess therapeutic efficacy in o...